Home
    Disclaimer

    1D-LSD Stats & Data

    Syn-l-229
    Chemical Class Lysergamide
    Psychoactive Class Psychedelic

    Receptor Profile

    Receptor Actions

    Agonists
    5-HT2A receptor agonist (partial)
    Other
    prodrug of LSD

    Effect Profile

    Curated + 4 Reports
    Psychedelic 5.4

    Strong visuals with moderate body load, mild headspace

    Visual Intensity×3
    8
    Headspace Depth×3
    5
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    6

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Cross-Tolerances

    LSD
    90% ●○○
    Psilocybin
    80% ●○○
    Psilocin
    80% ●○○
    Mescaline
    60% ●○○
    DMT
    80% ●○○
    5-MeO-DMT
    80% ●○○
    2C-B
    60% ●○○
    2C-E
    60% ●○○

    Experience Report Analysis

    Erowid
    4 Reports
    2022–2025 Date Range
    4 With Age Data
    5 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 4 experience reports (4 Erowid)

    4 Reports
    5 Effects Detected
    2 Positive
    1 Adverse
    2 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 2

    Music Enhancement 100.0% 70%
    Stimulation 75.0% 70%

    Adverse Effects 1

    Anxiety 75.0% 70%

    Form / Preparation

    Most common forms and preparations reported

    Legal Status

    Country Status Notes
    Austria According to the current legal situation, 1D-LSD is neither explicitly mentioned in the Narcotic Drugs Ordinance nor in the Psychotropic Substances Ordinance (SV/PV), thus it is neither to be classified as a narcotic drug in the sense of the SV nor as a psychotropic substance in the sense of the PV.
    Germany Since the 14 June 2024 1D-LSD (and 1T-LSD) are covered by the German NpSG law.
    ← Back to 1D-LSD